A clinical study ‘first’ conducted by Griffith University in Queensland has found that bolstering levels of Zinc and B6 in people presenting with Pyrrole Disorder led to a statistically significant decrease in symptoms and biological markers associated with the condition. What’s worth noting is that increasing B6 levels alone had no impact on the symptoms…
What Patients & Practitioners Are Saying
About Our Compounding Medicines